President-elect Donald Trump took on pharmaceutical companies this week saying such companies were "getting away with murder" based on their pricing practices, according to Reuters.
Here are three highlights:
1. Trump's rhetoric impacted many companies' stock prices. The ARCA pharmaceutical index closed Jan. 11, 2017, trading down 1.7 percent.
2. Brad Loncar, manager of the Loncar Cancer Immunotherapy Index, told Reuters that whenever someone high profile takes aim at an industry, it could impact investments in various products. However, Mr. Loncar noted drug pricing is a complicated issue as "there's not going to be clarity of drug pricing reform anytime soon."
3. Trump's language is not unique to the pharmaceutical industry, with the president-elect also saying Amazon was "getting away with murder" in May 2016 over the company's taxing practices.
